About Us
CRISPRomics®
+
CRISPRomics®
Publications
Pipeline
+
Pipeline®
Expanded Access Policy
News
People
+
Leadership Team
Board of Directors
Careers
Contact
Follow us on Twitter
Find us on LinkedIn
Nov 2022, Express™ Poster
Nov. 11, 2022
“ExPRESS™: An accelerated process for the manufacture of KSQ-001, a CRISPR/Cas9-edited
e
TIL® product”
© 2023 KSQ Therapeutics, Inc. All rights reserved.